Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study-Reference-Cited by-同舟云学术

Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study

Published:2017-08-14 Issue:8 Volume:12 Page:e0183191
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Domínguez Ángela^ORCID,Ciruela Pilar,Hernández Sergi,García-García Juan José,Soldevila Núria,Izquierdo Conchita,Moraga-Llop Fernando,Díaz Alvaro,F. de Sevilla Mariona,González-Peris Sebastià,Campins Magda,Uriona Sonia,Martínez-Osorio Johanna,Solé-Ribalta Anna,Codina Gemma,Esteva Cristina,Planes Ana María,Muñoz-Almagro Carmen,Salleras Luis

Funder

Plan Nacional I+D+I, ISCIII – Subdirección General de Evaluación y Fomento de la Investigación Sanitaria

Fondo Europeo de Desarrollo Regional (FEDER)

AGAUR

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference41 articles.

1. Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the sustainable development goals;L Liu;Lancet,2016

2. Pneumococcal capsules and their types: past, present, and future;KA Geno;Clin Microbiol Rev,2015

3. Safety and immunogenicity of a 13-valent-pneumococcal conjugated vaccine;KA Bryant;Pediatrics,2010